Name:
LA-MeO
IUPAC name:
(8β)-N-Ethyl-N-(methoxyethyl)-6-methyl-9,10-didehydroergoline-8-carboxamide
5081 · C21H27N3O2 · 353.458
InChI=1S/C21H27N3O2/c1-4-24(8-9-26-3)21(25)15-10-17-16-6-5-7-18-20(16)14(12-22-18)11-19(17)23(2)13-15/h5-7,10,12,15,19,22H,4,8-9,11,13H2,1-3H3/t15-,19-/m1/s1
BQPPMBUEDZCBOR-DNVCBOLYSA-N This stereoisomer Any stereoisomer
COCCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC

Parrish, JC. Toward a molecular understanding of hallucinogen action. Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 2006. 5.5 MB.

Nichols, DE. Structure-activity relationships of serotonin 5-HT2A agonists. WIREs Membr. Transp. Signal, 1 Sep 2012, 1 (5), 559-579. 573 kB. https://doi.org/10.1002/wmts.42 #31

1-Hydroxymethyl-LSD
UML-491 · Methysergide
12 November 2018 · Creative Commons BY-NC-SA ·